Development of an oral microemulsion formulation of alendronate: Effects of oil and co-surfactant type on phase behaviour

References

• Aboofazeli R, Lawrence CB, Wicks SR, Lawrence MJ. Investigations into the formation and characterization of phospholipid microemulsions. III. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an alkanoic acid, amine, alkanediol, polyethylene glycol alkyl ether or alcohol as cosurfactant. Int J Pharm 1994; 111: 63–72
   Web of Science ®Google Scholar
• Angelico R, Palazzo G, Colafemmina G, Cirkel PA, Giustini M, Ceglie A. Water diffusion and head group mobility in polymer-like reverse micelles: Evidence of a sphere-to-rod-to-sphere transition. J Phys Chem B 1998; 102: 2883–2889
   Web of Science ®Google Scholar
• Bagwe RP, Kanicky JR, Palla BJ, Patanjali PK, Shah DO. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carr Sys 2001; 18: 77–140
   PubMed Web of Science ®Google Scholar
• Binks BP, Espert A, Fletcher PDI, Soubiran L. Phase behaviour of microemulsions stabilized by double chain cationic surfactants and alcohol co-surfactants. Colloids Surf A Physicochem Eng Aspec 2003; 212: 135–145
   Web of Science ®Google Scholar
• Bone HG, Adami S, Rizzoli R, Favus M, Ross PD, Santora A, Prahalada S, Daifotis A, Orloff J, Yates J. Weekly administration of alendronate: rationale and plan for clinical assessment. Clin Ther 2000; 22: 15–28
   PubMed Web of Science ®Google Scholar
• Borgstrom B. Importance of phospholipids, pancreatic phospholipase A2 and fatty acid for the digestion of dietary fat. Gastroenterology 1980; 78: 954–962
   PubMed Web of Science ®Google Scholar
• Carey MC, Small DM, Bliss CM. Lipid digestion and absorption. Annu Rev Physiol 1983; 45: 651–677
   PubMed Web of Science ®Google Scholar
• Çilek A, Çelebi N, Tırnaksız F. Lecithin-based microemulsion of a peptide for oral administration: preparation, characterization, and physical stability of the formulation. Drug Deliv 2006; 13: 19–24
   PubMed Web of Science ®Google Scholar
• Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res 1995; 12: 1561–1572
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Lancaster CM, Marcello J, Chiossone D, Orner D, Hidalgo I, Smith PL, Sarkahian AB, Yiv SH, Owen AJ. Enhanced intestinal absorption of an RGD peptide from water-in-oil microemulsions of different composition and particle size. J Control Rel 1995; 34: 109–116
   Web of Science ®Google Scholar
• Constantinides PP, Scalart JP. Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides. Int J Pharm 1997; 158: 57–68
   Web of Science ®Google Scholar
• Constantinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H, Smith PL. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Re 1994; 11: 1385–1390
   Web of Science ®Google Scholar
• Cornell BA, Middlehurst J, Separovic F. Small unilamellar phospholipids vesicles and the theory of membrane formation. Faraday Disc Chem Soc 1986; 81: 163–167
   Google Scholar
• De Marco J, Biffar SE, Reed DG, Brooks MA. The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography. J Pharm Biomed Anal 1989; 7: 1719–1727
   PubMed Web of Science ®Google Scholar
• Fletcher PDI, Morris JS. Turbidity of oil-in-water microemulsion droplets stabilized by nonionic surfactants. Colloids Surf A: Physicochemi Engi Aspects 1995; 98: 147–154
   Web of Science ®Google Scholar
• Garcia-Celma MJ, Azemar N, Pes MA, Solans C. Solubilization of antifungal drugs in water/POE (20) sorbitan monooleate/oil systems. Int J Pharm 1994; 105: 77–81
   Web of Science ®Google Scholar
• Gasco MR, Gallarate M, Trotta M, Bauchiero L, Gremmo E, Chiappero O. Microemulsions as topical delivery vehicles: Ocular administration of timolol. J Pharm Biomed Anal 1989; 7: 433–439
   PubMed Web of Science ®Google Scholar
• Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 1995; 58: 288–298
   PubMed Web of Science ®Google Scholar
• Graham DY, Malaty HM, Goodgame R. Primary amino-bisphosphonates: a new class of gastrotoxic drugs-comparison of alendronate and aspirin. Am J Gastroenterol 1997; 92: 1322–1325
   PubMed Web of Science ®Google Scholar
• Hoar TP, Schulman JH. Transparent water-in-oil dispersions: the oleopathic hydro-micelle. Nature 1943; 152: 102
   Google Scholar
• Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Kazuyoshi M. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J Contr Rel 2002; 81: 65–74
   PubMed Web of Science ®Google Scholar
• Ke W-T, Lin S-Y, Ho H-O, Sheu M-T. Physical characterization of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. J Contr Rel 2005; 102: 489–507
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee EH, Vaishali B, Lee S, Lee Y-K, Kim C-Y, Moon HT, Byun Y. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates. J Contr Rel 2005; 105: 32–42
   PubMed Web of Science ®Google Scholar
• Kirk JK, Spangler JG. Alendronate: a bisphosphonate for treatment of osteoporosis. Clin Pharmacol 1996; 54: 2053–2060
   Google Scholar
• Kristis G. A viscosity study on oil-in water microemulsion. Int J Pharm 1990; 61: 213–218
   Web of Science ®Google Scholar
• Lawrence MJ. Microemulsions as drug delivery vehicles. Curr Opin Colloid Interface Sci 1994; 1: 826–832
   Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Del Rev 2000; 45: 89–121
   PubMed Web of Science ®Google Scholar
• Leung R, Shah DO. Microemulsions: an evolving technology for pharmaceutical applications. Controlled release of drugs: Polymers and aggregate systems, M Rossof. VCH, New York 1989; 85–215
   Google Scholar
• Lin JH, Chen I-W, Deluna FA, Hichens M. Role of calcium in plasma protein binding and renal handling of alendronate in hypo-and hypercalcemic rats. J Pharmacol Exp Ther 1993; 267: 670–675
   PubMed Web of Science ®Google Scholar
• Mehta SK, Kavaljit XX, Bala K. Phase behaviour, structural effects, volumetric and transport properties in nonaqueous microemulsions. Phys Rev E 1999; 59: 4317–4325
   Web of Science ®Google Scholar
• Osborne DW, Middleton CA, Rogers RL. Alcohol-free microemulsions. 1988; 9: 415–423
   Google Scholar
• Patil P, Joshi P, Paradkar A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS PharmSciTech 2004; 5: 1–8
   PubMed Web of Science ®Google Scholar
• Pattarino F, Marengo E, Gasco MR, Carpignano R. Experimental design and partial least squares in the study of complex mixtures: Microemulsions as drug carriers. Int J Pharm 1993; 91: 157–165
   Web of Science ®Google Scholar
• Porras AG, Holland SD, Gertz BJ. Pharmacokinetics of alendronate. Clin Pharmacokinet 1999; 36: 315–328
   PubMed Web of Science ®Google Scholar
• Ritschel WA. Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth Find Exp Clin Pharmacol 1991; 13: 205–220
   PubMed Web of Science ®Google Scholar
• Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice M-P, Czachur M, Daifotis AG. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998; 339: 292–299
   PubMed Web of Science ®Google Scholar
• Schurtenberger P, Peng Q, Leser ME, Luisi PL. Structure and phase behaviour of lecithin-based microemulsions: A study of chain length dependence. J Colloid Interface Sci 1993; 156: 43–51
   Web of Science ®Google Scholar
• Sharpe M, Noble S, Spencer CM. Alendronate an update of its use in osteoporosis. Drugs 2001; 61: 999–1039
   PubMed Web of Science ®Google Scholar
• Siebenbrodt I, Kiepert S. Poloxamer-systems as potential ophtyhalmics II. Micromemulsions. Eur J Pharm Biopharm 1993; 39: 25–30
   Web of Science ®Google Scholar
• Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carr Sys 1999; 16: 461–521
   PubMed Web of Science ®Google Scholar
• Trotta M, Cavalli R, Ugazio E, Gasco MR. Phase behaviour of microemulsion systems containing lecithin and lysolecithin as surfactants. Int J Pharm 1996; 143: 67–73
   Web of Science ®Google Scholar
• Türkyilmaz A, Çelebi N, Gonul B, Alkan-Onyuksel H. Physical characterization and stability of microemulsion for oral administration of a peptide. Biomedical science and technology, recent developments in the pharmaceutical and medical sciences, AA Hincal, HS Kas. Plenum Press, New York 1997; 65–72
   Google Scholar
• Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm 2000; 198: 7–27
   PubMed Web of Science ®Google Scholar
• Yaghmur A, Aserin A, Garti N. Phase behavior of microemulsions based on food-grade nonionic surfactants: Effect of polyols and short-chain alcohols. Colloids Surf A Physicochem Eng Aspec 2002; 209: 71–81
   Web of Science ®Google Scholar
• Yetkin G, Çelebi N, Özer Ç, Gönül B, Özoğul C. The healing effect of TGF-α on gastric ulcer induced by acetylsalicylic acid in rats. Int J Pharm 2004; 277: 163–172
   PubMed Web of Science ®Google Scholar
• Zhang XC, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 1996; 132: 195–206
   Web of Science ®Google Scholar